Clinical outcomes in patients with advanced epidermal growth factor receptor-mutated non-small-cell lung cancer in South Western Sydney Local Health District.
Ding, Pei N; Roberts, Tara L; Chua, Wei; Becker, Therese M; Descallar, Joseph; Yip, Po Y; Bray, Victoria.
Intern Med J
; 47(12): 1405-1411, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-28742280
Genome-wide copy number variation pattern analysis and a classification signature for non-small cell lung cancer.
NSCLC molecular testing in Central and Eastern European countries.
Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinoma.
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.
A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).
Molecular epidemiology of lung cancer in Iran: implications for drug development and cancer prevention.
Implications thérapeutiques des récentes études sur la stratégie de prise en charge des cancers bronchiques non àpetite cellule.
The role of mutation status of the epidermal growth factor receptor gene in advanced non-small cell lung cancer.
Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain.
Potential influence of interleukin-6 on the therapeutic effect of gefitinib in patients with advanced non-small cell lung cancer harbouring EGFR mutations.